What is PAT?
PAT (Process Analytical Technology) is a regulatory framework (FDA 2004) that enables the real-time monitoring and control of the manufacturing process.
Biologics manufacturing solutions for pharmaceutical manufacturers. The engagement covers the process control, the PAT (Process Analytical Technology), the bioreactor monitoring, the EBR implementation, the data analytics, and the validation.
The bioreactor monitoring covers the temperature, the pH, the dissolved oxygen, the agitation, the feed, the harvest, the data acquisition, the alarm management, and the data review.
The PAT (Process Analytical Technology) implementation covers the spectroscopic sensors (NIR, Raman), the at-line and on-line measurements, the chemometric models, the soft sensors, and the real-time release.
The process control covers the feed strategy, the temperature profile, the pH profile, the dissolved oxygen profile, the agitation strategy, the harvest criteria, and the data-driven optimization.
Use this Biologics Manufacturing page as a planning checkpoint before vendor selection, architecture review, validation scoping or implementation sequencing. The strongest next step is to compare the guidance with your current SOPs, system inventory, batch records, data flows and QA review routines so the discussion starts from evidence instead of assumptions.
For Biologics Manufacturing, prepare the records, owners, risks and decision criteria linked to bioreactor monitoring, pat implementation, process control. Useful evidence includes current process maps, interface lists, audit trail expectations, exception workflows, data retention rules and the business reason for changing the current operating model.
PAT (Process Analytical Technology) is a regulatory framework (FDA 2004) that enables the real-time monitoring and control of the manufacturing process.
The PAT model is validated per the GAMP 5 framework for AI/ML systems.